OCLN and melanoma: In the present study, our results showed that low-dose ABZ treatment significantly downregulated the expression of N-cadherin, Vimentin, Occludin, and FN1 and upregulated E-cadherin expression, indicating that low-dose ABZ can effectively reverse the EMT process of melanoma cells both in vivo and in vitro.